Amin Avinash 4

What Happened
Amin Avinash, a director of Neuronetics, was granted 30,000 restricted stock units (RSUs) on May 28, 2026. The reported acquisition price is $0.00 (i.e., an award, not a purchase), total reported value $0. This is a grant of compensation rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-05-28; Form filed: 2026-05-29 (timely filing).
• Transaction type: A = Award/Grant. Reported amount: 30,000 RSUs at $0.00.
• Shares owned after the transaction: not specified in the filing.
• Vesting and conversion: Each RSU is a contingent right to one share. Vesting occurs on the earlier of (a) May 28, 2027 or (b) the director’s Board-approved separation of service or a change in control, subject to continuous service (per filing footnotes).
• No tax-withholding, sale, or exercise reported with this grant.

Context
RSUs are a common form of equity compensation. They do not represent immediately tradable stock — they convert into shares only if and when they vest according to the stated conditions. This grant increases potential future equity ownership if Amin Avinash remains in service through the vesting conditions; it is not an immediate cash transaction and should be viewed as compensation, not a direct market signal.